BG105556A - New esters derived from substituted phenyl-cyclohexyl compounds - Google Patents

New esters derived from substituted phenyl-cyclohexyl compounds

Info

Publication number: BG105556A
Authority: BG; Bulgaria
Prior art keywords: substituted phenyl; esters derived; new esters; compounds; cyclohexyl compounds
Prior art date: 1998-11-06

Application number

BG105556A

Other languages

Bulgarian (bg)

English (en)

Inventor

CASTILLO NIETO Juan DEL

Freixa Maria Chalaux

Clotet Joan Huguet

MANCCINI Marisabel MOURELLE

Ramon Amat Elisabet De

Original Assignee

Laboratorios Vita,S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-06

Filing date

2001-06-01

Publication date

2001-12-29

2001-06-01 Application filed by Laboratorios Vita,S.A. filed Critical Laboratorios Vita,S.A.

2001-12-29 Publication of BG105556A publication Critical patent/BG105556A/xx

Links

150000002148 esters Chemical class 0.000 title abstract 3
125000004351 phenylcyclohexyl group Chemical group C1(=CC=CC=C1)C1(CCCCC1)* 0.000 title abstract 2
TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 abstract 2
230000000202 analgesic effect Effects 0.000 abstract 2
229960004380 tramadol Drugs 0.000 abstract 2
TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C219/30—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BG105556A 1998-11-06 2001-06-01 New esters derived from substituted phenyl-cyclohexyl compounds BG105556A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES009802329A ES2141688B1 (es)	1998-11-06	1998-11-06	Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
PCT/ES1999/000352 WO2000027799A1 (fr)	1998-11-06	1999-11-04	Nouveaux esters derives de composes phenyl-cyclohexyle substitues

Publications (1)

Publication Number	Publication Date
BG105556A true BG105556A (en)	2001-12-29

Family

ID=8305698

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG105556A BG105556A (en)	1998-11-06	2001-06-01	New esters derived from substituted phenyl-cyclohexyl compounds

Country Status (39)

Country	Link
US (1)	US6455585B1 (fr)
EP (3)	EP1219594B1 (fr)
JP (1)	JP2002529442A (fr)
KR (1)	KR100453613B1 (fr)
CN (1)	CN1176902C (fr)
AP (1)	AP1222A (fr)
AT (3)	ATE249418T1 (fr)
AU (1)	AU755681B2 (fr)
BG (1)	BG105556A (fr)
BR (1)	BR9915727A (fr)
CA (1)	CA2349245A1 (fr)
CR (1)	CR6368A (fr)
CU (1)	CU23006A3 (fr)
CZ (1)	CZ20011500A3 (fr)
DE (3)	DE69911235T2 (fr)
DK (3)	DK1127871T3 (fr)
EA (1)	EA003742B1 (fr)
EE (1)	EE200100246A (fr)
ES (4)	ES2141688B1 (fr)
GE (1)	GEP20033116B (fr)
HR (1)	HRP20010412B1 (fr)
HU (1)	HUP0104218A3 (fr)
ID (1)	ID29017A (fr)
IL (1)	IL142592A0 (fr)
IS (1)	IS5934A (fr)
MA (1)	MA26765A1 (fr)
MX (1)	MXPA01004432A (fr)
NO (1)	NO20012234D0 (fr)
NZ (1)	NZ511739A (fr)
OA (1)	OA11672A (fr)
PL (1)	PL347492A1 (fr)
PT (3)	PT1219594E (fr)
SI (3)	SI1127871T1 (fr)
SK (1)	SK284068B6 (fr)
TR (3)	TR200200415T2 (fr)
UA (1)	UA59477C2 (fr)
WO (1)	WO2000027799A1 (fr)
YU (1)	YU29601A (fr)
ZA (1)	ZA200104026B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2160534B1 (es) *	1999-12-30	2002-04-16	Vita Invest Sa	Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10049483A1 (de) *	2000-09-29	2002-05-02	Gruenenthal Gmbh	Substituierte 1-Aminobutan-3-ol-Derivate
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
WO2004026291A1 (fr) *	2002-08-28	2004-04-01	Shuyi Zhang	Formulations orales d'ibuprofene et de tramadol, methodes de preparation de ces dernieres
PT1562567T (pt)	2002-11-22	2017-08-24	Gruenenthal Gmbh	Combinação de analgésicos selecionados e inibidores da cox-ii
US20040248979A1 (en) *	2003-06-03	2004-12-09	Dynogen Pharmaceuticals, Inc.	Method of treating lower urinary tract disorders
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en)	2003-08-06	2011-12-13	Gruenenthal Gmbh	Abuse-proofed dosage form
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE102004032051A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004034619A1 (de) *	2004-07-16	2006-02-23	Grünenthal GmbH	Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
KR101616246B1 (ko)	2008-01-25	2016-05-02	그뤼넨탈 게엠베하	약제학적 투여형
AU2009243681B2 (en)	2008-05-09	2013-12-19	Grunenthal Gmbh	Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
WO2011009602A1 (fr)	2009-07-22	2011-01-27	Grünenthal GmbH	Forme galénique extrudée à chaud à libération contrôlée
TWI473628B (zh)	2009-07-22	2015-02-21		用於對氧化敏感之類鴉片藥劑之抗破壞劑型
EP2383255A1 (fr)	2010-04-28	2011-11-02	Lacer, S.A.	Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
CA2808219C (fr)	2010-09-02	2019-05-14	Gruenenthal Gmbh	Forme pharmaceutique inviolable comportant un sel inorganique
WO2012028318A1 (fr)	2010-09-02	2012-03-08	Grünenthal GmbH	Forme pharmaceutique inviolable comportant un polymère anionique
WO2012100423A1 (fr)	2011-01-27	2012-08-02	Eli Lilly And Company	Composés analgésiques, procédés, et formulations
EP2530072A1 (fr)	2011-06-03	2012-12-05	Lacer, S.A.	Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
US10702485B2 (en)	2011-07-09	2020-07-07	Syntrix Biosystems Inc.	Compositions and methods for overcoming resistance to tramadol
AU2012289764B2 (en)	2011-07-29	2017-03-02	Grünenthal GmbH	Tamper-resistant tablet providing immediate drug release
ES2648129T3 (es)	2011-07-29	2017-12-28	Grünenthal GmbH	Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
US20130225697A1 (en)	2012-02-28	2013-08-29	Grunenthal Gmbh	Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
PL2838512T3 (pl)	2012-04-18	2018-12-31	Grünenthal GmbH	Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
WO2013168005A2 (fr) *	2012-05-10	2013-11-14	Mahesh Kandula	Compositions et méthodes de traitement du syndrome des jambes sans repos et de la fibromyalgie
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6466417B2 (ja)	2013-05-29	2019-02-06	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
AU2014273227B2 (en)	2013-05-29	2019-08-15	Grunenthal Gmbh	Tamper-resistant dosage form containing one or more particles
JP6449871B2 (ja)	2013-07-12	2019-01-09	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	エチレン−酢酸ビニルポリマーを含有する改変防止剤形
EP3073994A1 (fr)	2013-11-26	2016-10-05	Grünenthal GmbH	Préparation de composition pharmaceutique en poudre par cryo-broyage
EP3142646A1 (fr)	2014-05-12	2017-03-22	Grünenthal GmbH	Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol
BR112017021475A2 (pt)	2015-04-24	2018-07-10	Gruenenthal Gmbh	forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
WO2017042325A1 (fr)	2015-09-10	2017-03-16	Grünenthal GmbH	Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1199764B (de) *	1963-04-02	1965-09-02	Gruenenthal Chemie	Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) *	1967-07-27	1972-03-28	Gruenenthal Chemie	1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19525137C2 (de) *	1995-07-11	2003-02-27	Gruenenthal Gmbh	6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) *	1996-03-13	1997-09-18	Gruenenthal Gmbh	Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

1998
- 1998-11-06 ES ES009802329A patent/ES2141688B1/es not_active Expired - Fee Related
1999
- 1999-04-11 UA UA2001063799A patent/UA59477C2/uk unknown
- 1999-11-04 EP EP02075838A patent/EP1219594B1/fr not_active Expired - Lifetime
- 1999-11-04 HU HU0104218A patent/HUP0104218A3/hu unknown
- 1999-11-04 SI SI9930450T patent/SI1127871T1/xx unknown
- 1999-11-04 GE GEAP19995930A patent/GEP20033116B/en unknown
- 1999-11-04 PL PL99347492A patent/PL347492A1/xx unknown
- 1999-11-04 CA CA002349245A patent/CA2349245A1/fr not_active Abandoned
- 1999-11-04 ES ES02075838T patent/ES2213732T3/es not_active Expired - Lifetime
- 1999-11-04 MX MXPA01004432A patent/MXPA01004432A/es unknown
- 1999-11-04 CZ CZ20011500A patent/CZ20011500A3/cs unknown
- 1999-11-04 TR TR2002/00415T patent/TR200200415T2/xx unknown
- 1999-11-04 JP JP2000580979A patent/JP2002529442A/ja active Pending
- 1999-11-04 YU YU29601A patent/YU29601A/sh unknown
- 1999-11-04 AU AU10473/00A patent/AU755681B2/en not_active Ceased
- 1999-11-04 AT AT99953994T patent/ATE249418T1/de not_active IP Right Cessation
- 1999-11-04 ID IDW00200101215A patent/ID29017A/id unknown
- 1999-11-04 AT AT02075838T patent/ATE257817T1/de not_active IP Right Cessation
- 1999-11-04 ES ES99953994T patent/ES2207298T3/es not_active Expired - Lifetime
- 1999-11-04 KR KR10-2001-7005667A patent/KR100453613B1/ko not_active Expired - Fee Related
- 1999-11-04 TR TR2002/00416T patent/TR200200416T2/xx unknown
- 1999-11-04 PT PT02075838T patent/PT1219594E/pt unknown
- 1999-11-04 DE DE69911235T patent/DE69911235T2/de not_active Expired - Fee Related
- 1999-11-04 CN CNB998129259A patent/CN1176902C/zh not_active Expired - Fee Related
- 1999-11-04 NZ NZ511739A patent/NZ511739A/xx unknown
- 1999-11-04 US US09/831,177 patent/US6455585B1/en not_active Expired - Fee Related
- 1999-11-04 EE EEP200100246A patent/EE200100246A/xx unknown
- 1999-11-04 IL IL14259299A patent/IL142592A0/xx unknown
- 1999-11-04 BR BR9915727-6A patent/BR9915727A/pt not_active IP Right Cessation
- 1999-11-04 OA OA1200100111A patent/OA11672A/en unknown
- 1999-11-04 DE DE69914231T patent/DE69914231T2/de not_active Expired - Fee Related
- 1999-11-04 AP APAP/P/2001/002161A patent/AP1222A/en active
- 1999-11-04 DK DK99953994T patent/DK1127871T3/da active
- 1999-11-04 DK DK02075838T patent/DK1219594T3/da active
- 1999-11-04 PT PT02075837T patent/PT1219623E/pt unknown
- 1999-11-04 PT PT99953994T patent/PT1127871E/pt unknown
- 1999-11-04 DK DK02075837T patent/DK1219623T3/da active
- 1999-11-04 HR HR20010412A patent/HRP20010412B1/xx not_active IP Right Cessation
- 1999-11-04 AT AT02075837T patent/ATE257837T1/de not_active IP Right Cessation
- 1999-11-04 TR TR2001/01160T patent/TR200101160T2/xx unknown
- 1999-11-04 SI SI9930541T patent/SI1219623T1/xx unknown
- 1999-11-04 SI SI9930540T patent/SI1219594T1/xx unknown
- 1999-11-04 EP EP02075837A patent/EP1219623B1/fr not_active Expired - Lifetime
- 1999-11-04 EA EA200100476A patent/EA003742B1/ru not_active IP Right Cessation
- 1999-11-04 ES ES02075837T patent/ES2213731T3/es not_active Expired - Lifetime
- 1999-11-04 EP EP99953994A patent/EP1127871B1/fr not_active Expired - Lifetime
- 1999-11-04 WO PCT/ES1999/000352 patent/WO2000027799A1/fr not_active Ceased
- 1999-11-04 DE DE69914229T patent/DE69914229T2/de not_active Expired - Fee Related
- 1999-11-04 SK SK584-2001A patent/SK284068B6/sk unknown
2001
- 2001-05-03 IS IS5934A patent/IS5934A/is unknown
- 2001-05-04 NO NO20012234A patent/NO20012234D0/no unknown
- 2001-05-07 CU CU2001010920010109A patent/CU23006A3/es unknown
- 2001-05-16 CR CR6368A patent/CR6368A/es not_active Application Discontinuation
- 2001-05-17 ZA ZA200104026A patent/ZA200104026B/en unknown
- 2001-05-23 MA MA26211A patent/MA26765A1/fr unknown
- 2001-06-01 BG BG105556A patent/BG105556A/xx unknown

Also Published As

Publication number	Publication date
DE69911235D1 (de)	2003-10-16
EA200100476A1 (ru)	2002-02-28
ID29017A (id)	2001-07-26
DE69914231D1 (de)	2004-02-19
TR200200416T2 (tr)	2003-01-21
ZA200104026B (en)	2002-05-17
NZ511739A (en)	2002-11-26
SK5842001A3 (en)	2001-12-03
ES2207298T3 (es)	2004-05-16
EP1219594B1 (fr)	2004-01-14
EP1219594A1 (fr)	2002-07-03
EP1219623B1 (fr)	2004-01-14
ES2213731T3 (es)	2004-09-01
HRP20010412A2 (en)	2002-12-31
UA59477C2 (uk)	2003-09-15
CU23006A3 (es)	2004-12-17
PT1219623E (pt)	2004-04-30
MXPA01004432A (es)	2002-09-18
NO20012234L (no)	2001-05-04
TR200200415T2 (tr)	2002-06-21
GEP20033116B (en)	2003-11-25
CN1325377A (zh)	2001-12-05
IS5934A (is)	2001-05-03
CR6368A (es)	2002-04-08
WO2000027799A1 (fr)	2000-05-18
TR200101160T2 (tr)	2002-01-21
SI1219594T1 (en)	2004-06-30
YU29601A (sh)	2003-04-30
EP1127871B1 (fr)	2003-09-10
SI1219623T1 (en)	2004-06-30
SK284068B6 (sk)	2004-09-08
BR9915727A (pt)	2001-09-04
EA003742B1 (ru)	2003-08-28
HUP0104218A3 (en)	2002-11-28
KR20010080942A (ko)	2001-08-25
PT1127871E (pt)	2003-12-31
AU1047300A (en)	2000-05-29
KR100453613B1 (ko)	2004-10-20
JP2002529442A (ja)	2002-09-10
CZ20011500A3 (cs)	2001-09-12
DE69914229T2 (de)	2004-12-09
DK1219594T3 (da)	2004-04-19
ATE249418T1 (de)	2003-09-15
HRP20010412B1 (en)	2004-04-30
ATE257837T1 (de)	2004-01-15
US6455585B1 (en)	2002-09-24
AU755681B2 (en)	2002-12-19
SI1127871T1 (en)	2004-02-29
PL347492A1 (en)	2002-04-08
CN1176902C (zh)	2004-11-24
CA2349245A1 (fr)	2000-05-18
PT1219594E (pt)	2004-04-30
ES2141688A1 (es)	2000-05-16
NO20012234D0 (no)	2001-05-04
EP1127871A1 (fr)	2001-08-29
DE69914229D1 (de)	2004-02-19
DK1127871T3 (da)	2003-11-24
DK1219623T3 (da)	2004-04-19
EE200100246A (et)	2002-12-16
ES2141688B1 (es)	2001-02-01
HUP0104218A2 (hu)	2002-03-28
AP1222A (en)	2003-11-06
ES2213732T3 (es)	2004-09-01
ATE257817T1 (de)	2004-01-15
DE69914231T2 (de)	2004-11-11
OA11672A (en)	2005-01-12
IL142592A0 (en)	2002-03-10
MA26765A1 (fr)	2004-12-20
DE69911235T2 (de)	2004-07-01
EP1219623A1 (fr)	2002-07-03

Publication	Publication Date	Title
BG105556A (en)	2001-12-29	New esters derived from substituted phenyl-cyclohexyl compounds
NZ237023A (en)	1993-01-27	17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
MY104926A (en)	1994-07-30	Quinoline, quinazoline and cinnoline derivatives
PL343495A1 (en)	2001-08-27	Heterocyclically substituted amides used as calpain inhibitors
MD1315B1 (en)	1999-09-30	Oxim esters and intermediate compositions, process for preparation thereof, compositions, process for pests control.
SG80530A1 (en)	2001-05-22	Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen
BG106586A (en)	2003-01-31	Pyrazolopyramidines as therapeutic agents
GEP20033044B (en)	2003-08-25	Method for Treating Atherosclerosis
EP0840606A4 (fr)	1998-05-13
SG49228A1 (en)	1998-05-18	Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity
IL110943A0 (en)	1994-11-28	Compositions for the treatment of skin disorders
WO2002034201A3 (fr)	2003-03-27	Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
CA2264063A1 (fr)	1998-03-05	Composes de cryptophycine
SI0989973T1 (sl)	2006-02-28	Halkoni z antiproliferativno aktivnostjo
TWI256292B (en)	2006-06-11	Reduction inhibitory agent for active oxygen eliminating activity
GB9907571D0 (en)	1999-05-26	Compounds
MY106522A (en)	1995-06-30	Arylaminocarbonyl compounds.
TW325997B (en)	1998-02-01	Pharmaceutical composition for preventing and treating retinal diseases
NO973366L (no)	1997-07-21	Fremgangsmåte for behandling av multippel sklerose
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ZA9711719B (en)	1998-06-25	Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis.
MY140504A (en)	2009-12-31	Statin-mmp inhibitor combinations
AR005866A1 (es)	1999-07-21	Composicion farmaceutica antioxidante
ZA954766B (en)	1996-12-09	Fungicidal mixtures
MXPA02002486A (es)	2004-09-10	Uso de dexrazoxano para tratar la psoriasis.